Mechanism of action at the cellular level
The primary site of drug action is the GABA-A receptor complex. The active substance binds to specific "barbiturate" sites on this receptor. As a result of this interaction, allosteric changes occur in the receptor, and its sensitivity to the main inhibitory neurotransmitter — gamma-aminobutyric acid (GABA) — increases sharply.
The consequence of this process is an increased influx of negatively charged chloride ions ($Cl^-$) into the neuron. Cell membrane hyperpolarization occurs, leading to a significant decrease in nerve cell excitability, especially in the epileptogenic focus.
In addition, additional mechanisms are hypothesized:
- Changes in membrane permeability for other important ions: sodium ($Na^+$), potassium ($K^+$), and calcium ($Ca^{2+}$).
- Antagonism toward glutamate, the main excitatory neurotransmitter in the central nervous system.
Pharmacological effects and indications for use
The anticonvulsant properties of this compound have been used in medicine since 1910. In addition to its antiepileptic effect, the substance exerts a strong sedative and hypnotic effect. In clinical practice for the treatment of epilepsy, the drug is prescribed in subhypnotic doses, but sedation very frequently persists as a background side effect.
Main indications for prescription:
- Prevention of generalized tonic-clonic seizures.
- Prevention of partial seizures.
- Emergency management of status epilepticus.
The drug is available in several dosage forms. For planned prophylactic oral intake, tablets and solutions are used. For emergency management of status epilepticus, intravenous administration (as the sodium salt) is used.
Pharmacokinetic features
Upon oral administration, the drug is absorbed completely, but rather slowly. The maximum blood concentration ($T_{max}$) is reached in 1–2 hours. The substance binds to plasma proteins by approximately 50%, after which it is slowly and evenly distributed across the body's organs and tissues.
Metabolism occurs in the liver with the formation of an inactive metabolite — 4-hydroxyphenobarbital. A crucial feature of the drug is that it is a potent inducer of hepatic microsomal enzymes. Because of this, it accelerates the breakdown of other drugs and also triggers the process of autoinduction (accelerates its own metabolism).
Elimination is carried out by the kidneys in the form of glucuronide, with about 25% of the substance leaving the body unchanged. The half-life ($t_{1/2}$) is very long: 2–4 days in adults and up to 7 days in newborns. This causes a pronounced cumulative effect — the ability of the drug to accumulate in the body with regular intake.
Side effects and contraindications
Due to its prolonged presence in the body and ability to accumulate, therapy is often accompanied by adverse reactions:
- Central nervous system: persistent drowsiness, ataxia, feeling of malaise, development of depression.
- Somatic manifestations: arterial hypotension, nausea, and vomiting.
- Allergic reactions: skin rash.
The consequences of prolonged continuous intake are the formation of drug dependence and the development of tolerance (habituation, where a larger dose is required to achieve the previous effect).
Prescribing the drug is strictly contraindicated during pregnancy and lactation, severe liver and kidney diseases, myasthenia gravis, and established hypersensitivity to barbiturates.
Related anticonvulsant drugs
This same group includes other barbituric acid derivatives and structurally related compounds:
- Benzobarbital (Benzonal). Used for the prevention of generalized tonic-clonic seizures. It has a side effect profile analogous to barbiturates (drowsiness, headache, ataxia, speech disorders, and weakness).
- Primidone (Hexamidine). Chemically a pyrimidine derivative, but structurally very similar to the main drug. It is also used to prevent generalized seizures, but has an important advantage: it is less toxic and causes significantly less drowsiness.
Briefly: answers to topical questions
What are the absolute contraindications to prescribing phenobarbital?
Absolute contraindications to prescribing phenobarbital are pregnancy and lactation, severe liver and kidney diseases, myasthenia gravis, and hypersensitivity to the drug.
With which specific drug groups does phenobarbital enter into clinically significant interactions due to hepatic enzyme induction?
Phenobarbital is a potent inducer of hepatic microsomal enzymes, accelerates the metabolism and reduces the efficacy of oral contraceptives (estrogens), as well as such medicinal substances as digoxin, theophylline, and quinidine.
What are the symptoms of acute phenobarbital poisoning?
Mild intoxication is characterized by drowsiness, coordination disorders, slurred speech, tachycardia, miosis, and shallow breathing. Severe intoxication manifests as a coma with absent pupillary light reflex, respiratory depression, drop in blood pressure up to cardiac dysfunction, and death from respiratory arrest.
What supportive measures and specific antidotes are used in acute phenobarbital poisoning?
To treat barbiturate poisoning, analeptics are used, specifically bemegride, which directly stimulates the respiratory and vasomotor centers, as well as nikethamide (coriamin), administered parenterally. In addition, to accelerate the elimination of weak acids, urine alkalinization by administration of sodium bicarbonate is used.
Why is phenobarbital used in pediatrics to treat neonatal jaundice?
Phenobarbital is used due to its properties as an inducer of hepatic microsomal enzymes. It increases the synthesis and activity of UDP-glucuronosyltransferase, which accelerates the conjugation of toxic unconjugated bilirubin and promotes its elimination from the newborn's body.
To remember the mechanism: "Barbiturates Block Painful activity, Bringing more chlorine in." Chloride ions (Cl-) are negatively charged, so inside the neuron it becomes "even more negative" — this is hyperpolarization, which inhibits the cell.
Class and exam questions
Why do patients complain of lethargy during phenobarbital treatment, even if the dose is not hypnotic?
The drug is indeed prescribed in subhypnotic doses for the treatment of epilepsy, but its sedative effect is very strong and often persists as a background side effect.
What is phenobarbital autoinduction?
This is the ability of the drug to stimulate the work of hepatic microsomal enzymes, as a result of which it begins to accelerate not only the metabolism of other drugs, but also its own degradation.
Can this drug be used during pregnancy?
No, pregnancy and the lactation period are strict contraindications to prescribing this agent.
What else to study on this topic
- Allosteric modulation of GABA-A receptors
- The role of hepatic microsomal enzymes in drug interactions
- Comparative characteristics of barbiturates and benzodiazepines
- Mechanisms of drug tolerance and dependence development
- Pharmacokinetic features of drugs with a pronounced cumulative effect
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Phenobarbital" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.